JP2025507372A5 - - Google Patents
Info
- Publication number
- JP2025507372A5 JP2025507372A5 JP2024547599A JP2024547599A JP2025507372A5 JP 2025507372 A5 JP2025507372 A5 JP 2025507372A5 JP 2024547599 A JP2024547599 A JP 2024547599A JP 2024547599 A JP2024547599 A JP 2024547599A JP 2025507372 A5 JP2025507372 A5 JP 2025507372A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna agent
- agent according
- nucleotides
- nucleotide
- tau
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263309399P | 2022-02-11 | 2022-02-11 | |
| US63/309,399 | 2022-02-11 | ||
| US202263322618P | 2022-03-22 | 2022-03-22 | |
| US63/322,618 | 2022-03-22 | ||
| PCT/US2023/062440 WO2023154900A2 (en) | 2022-02-11 | 2023-02-10 | Microtubule associated protein tau (mapt) irna agent compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507372A JP2025507372A (ja) | 2025-03-18 |
| JP2025507372A5 true JP2025507372A5 (cg-RX-API-DMAC7.html) | 2026-02-17 |
Family
ID=87565165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547599A Pending JP2025507372A (ja) | 2022-02-11 | 2023-02-10 | 微小管関連タンパク質タウ(MAPT)iRNA剤組成物およびその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250171777A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4476338A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507372A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023154900A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025212467A1 (en) | 2024-03-31 | 2025-10-09 | Arrowhead Pharmaceuticals, Inc. | Rnai agents for inhibiting expression of microtubule associated protein tau (mapt), compositions thereof, and methods of use |
| WO2026048822A1 (ja) * | 2024-08-30 | 2026-03-05 | 東亞合成株式会社 | Mapt rna配列に基づく新規二本鎖rna及びその利用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0605337D0 (en) * | 2006-03-17 | 2006-04-26 | Genomica Sau | Treatment of CNS conditions |
| WO2008124066A1 (en) * | 2007-04-05 | 2008-10-16 | The J. David Gladstone Institutes | Agents that reduce neuronal overexcitation |
| ES2820713T3 (es) * | 2015-03-25 | 2021-04-22 | Univ Degli Studi Di Trento | Terapia mediada por ARN interferente para enfermedades neurodegenerativas |
| JP2023518439A (ja) * | 2020-03-18 | 2023-05-01 | ユニバーシティー オブ マサチューセッツ | Mapt調節のためのオリゴヌクレオチド |
| JP2023521604A (ja) * | 2020-03-30 | 2023-05-25 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 微小管関連タンパク質タウ(MAPT)iRNA剤組成物およびその使用方法 |
| CN116761616A (zh) * | 2021-01-22 | 2023-09-15 | 阿耐拉姆制药公司 | 经修饰的双链寡核苷酸 |
-
2023
- 2023-02-10 US US18/837,453 patent/US20250171777A1/en active Pending
- 2023-02-10 EP EP23753727.9A patent/EP4476338A4/en active Pending
- 2023-02-10 WO PCT/US2023/062440 patent/WO2023154900A2/en not_active Ceased
- 2023-02-10 JP JP2024547599A patent/JP2025507372A/ja active Pending